Dr GRAHAM SHERIDAN GRAHAM.SHERIDAN@NOTTINGHAM.AC.UK
Assistant Professor
Targeting S1P receptors in experimental autoimmune encephalomyelitis in mice improves early deficits in locomotor activity and increases ultrasonic vocalisations
Sheridan, Graham K.; Dev, Kumlesh K.
Authors
Kumlesh K. Dev
Contributors
Dr GRAHAM SHERIDAN GRAHAM.SHERIDAN@NOTTINGHAM.AC.UK
Researcher
Abstract
Fingolimod (FTY720) is an oral therapy for relapsing remitting multiple sclerosis (MS) and targets sphingosine 1-phosphate receptors (S1PRs). FTY720 also rescues animals from experimental autoimmune encephalomyelitis (EAE), an animal model of MS. The protective effects of FTY720 in EAE are primarily scored manually by examining weight loss and limb paralysis that begins around 10-12 days after immunisation. To our knowledge, pre-clinical effects of FTY720 on animal behaviour early in EAE have not been explored. Here, we developed an automated behaviour monitoring system to examine the early effects of FTY720 on subtle pre-symptomatic behaviour of mice induced with EAE. Our automated home-cage monitoring system (AHC-MS) enabled non-contact detection of movement and ultrasonic vocalisations (USVs) of mice induced with EAE, thus allowing detection of subtle changes in mouse behaviour before paralysis occurs. Mice receiving FTY720 emit longer USVs and display higher levels of motor activity than vehicle-treated EAE mice before clinical symptoms become apparent. Importantly, this study promotes the 3Rs ethics (replacement, reduction and refinement) in the EAE animal model and may also improve pre-screening of potentially novel MS therapies. In addition, this is the first report showing the early effects of FTY720 in EAE which underscores its protective effects.
Citation
Sheridan, G. K., & Dev, K. K. (2014). Targeting S1P receptors in experimental autoimmune encephalomyelitis in mice improves early deficits in locomotor activity and increases ultrasonic vocalisations. Scientific Reports, 4(1), https://doi.org/10.1038/srep05051
Journal Article Type | Article |
---|---|
Acceptance Date | May 6, 2014 |
Online Publication Date | May 23, 2014 |
Publication Date | May 23, 2014 |
Deposit Date | Jan 13, 2020 |
Publicly Available Date | Jan 23, 2020 |
Journal | Scientific Reports |
Print ISSN | 2045-2322 |
Electronic ISSN | 2045-2322 |
Publisher | Nature Publishing Group |
Peer Reviewed | Peer Reviewed |
Volume | 4 |
Issue | 1 |
Article Number | 5051 |
DOI | https://doi.org/10.1038/srep05051 |
Keywords | Multidisciplinary |
Public URL | https://nottingham-repository.worktribe.com/output/3590930 |
Publisher URL | https://www.nature.com/articles/srep05051 |
Files
Targeting S1P Receptors In EAE
(764 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/3.0/
You might also like
Poroelastic osmoregulation of living cell volume
(2021)
Journal Article
Tumour brain: pre‐treatment cognitive and affective disorders caused by peripheral cancers
(2021)
Journal Article
Extracellular Vesicles and Intercellular Communication in the Central Nervous System
(2021)
Journal Article
Mechanobiology of the brain in ageing and Alzheimer's disease
(2020)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: digital-library-support@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search